Nephron Number As Predictor of Corticosteroid Response in Adult Minimal Change Disease

Overview

Journal Kidney Med

Specialty Nephrology

Date 2020 Oct 22

PMID 33090125

Authors

Bartholomeus T van den Berge

Rutger J Maas

Affiliations

Soon will be listed here.

References

Sasaki T, Tsuboi N, Kanzaki G, Haruhara K, Okabayashi Y, Koike K . Biopsy-based estimation of total nephron number in Japanese living kidney donors. Clin Exp Nephrol. 2019; 23(5):629-637. DOI: 10.1007/s10157-018-01686-2. View

Waldman M, John Crew R, Valeri A, Busch J, Stokes B, Markowitz G . Adult minimal-change disease: clinical characteristics, treatment, and outcomes. Clin J Am Soc Nephrol. 2007; 2(3):445-53. DOI: 10.2215/CJN.03531006. View

Sasaki T, Tsuboi N, Okabayashi Y, Haruhara K, Kanzaki G, Koike K . Estimation of nephron number in living humans by combining unenhanced computed tomography with biopsy-based stereology. Sci Rep. 2019; 9(1):14400. PMC: 6779756. DOI: 10.1038/s41598-019-50529-x. View

Sasaki T, Tsuboi N, Marumoto H, Okabayashi Y, Haruhara K, Kanzaki G . Nephron Number and Time to Remission in Steroid-Sensitive Minimal Change Disease. Kidney Med. 2020; 2(5):559-568.e1. PMC: 7568083. DOI: 10.1016/j.xkme.2020.05.011. View

Muller-Deile J, Schiffer M . Podocyte directed therapy of nephrotic syndrome-can we bring the inside out?. Pediatr Nephrol. 2015; 31(3):393-405. DOI: 10.1007/s00467-015-3116-4. View

Ruggenenti P, Debiec H, Ruggiero B, Chianca A, Pelle T, Gaspari F . Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy. J Am Soc Nephrol. 2015; 26(10):2545-58. PMC: 4587688. DOI: 10.1681/ASN.2014070640. View

Brenner B, Chertow G . Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury. Am J Kidney Dis. 1994; 23(2):171-5. View

Venkatareddy M, Wang S, Yang Y, Patel S, Wickman L, Nishizono R . Estimating podocyte number and density using a single histologic section. J Am Soc Nephrol. 2013; 25(5):1118-29. PMC: 4005315. DOI: 10.1681/ASN.2013080859. View

Hoy W, Douglas-Denton R, Hughson M, Cass A, Johnson K, Bertram J . A stereological study of glomerular number and volume: preliminary findings in a multiracial study of kidneys at autopsy. Kidney Int Suppl. 2003; (83):S31-7. DOI: 10.1046/j.1523-1755.63.s83.8.x. View

10.

Medjeral-Thomas N, Lawrence C, Condon M, Sood B, Warwicker P, Brown H . Randomized, Controlled Trial of Tacrolimus and Prednisolone Monotherapy for Adults with Minimal Change Disease: A Multicenter, Randomized, Controlled Trial. Clin J Am Soc Nephrol. 2020; 15(2):209-218. PMC: 7015084. DOI: 10.2215/CJN.06180519. View

11.

Remy P, Audard V, Natella P, Pelle G, Dussol B, Leray-Moragues H . An open-label randomized controlled trial of low-dose corticosteroid plus enteric-coated mycophenolate sodium versus standard corticosteroid treatment for minimal change nephrotic syndrome in adults (MSN Study). Kidney Int. 2018; 94(6):1217-1226. DOI: 10.1016/j.kint.2018.07.021. View

12.

Koike K, Tsuboi N, Utsunomiya Y, Kawamura T, Hosoya T . Glomerular density-associated changes in clinicopathological features of minimal change nephrotic syndrome in adults. Am J Nephrol. 2011; 34(6):542-8. DOI: 10.1159/000334360. View

13.

Siegerist F, Ribback S, Dombrowski F, Amann K, Zimmermann U, Endlich K . Structured illumination microscopy and automatized image processing as a rapid diagnostic tool for podocyte effacement. Sci Rep. 2017; 7(1):11473. PMC: 5597580. DOI: 10.1038/s41598-017-11553-x. View

14.

Puelles V, Fleck D, Ortz L, Papadouri S, Strieder T, Bohner A . Novel 3D analysis using optical tissue clearing documents the evolution of murine rapidly progressive glomerulonephritis. Kidney Int. 2019; 96(2):505-516. DOI: 10.1016/j.kint.2019.02.034. View

15.

Kronbichler A, Gauckler P, Bruchfeld A . Rituximab in minimal change disease and focal segmental glomerulosclerosis. Nephrol Dial Transplant. 2019; 36(6):983-985. DOI: 10.1093/ndt/gfz205. View

16.

Yoshizawa N, Kusumi Y, Matsumoto K, Oshima S, Takeuchi A, Kawamura O . Studies of a glomerular permeability factor in patients with minimal-change nephrotic syndrome. Nephron. 1989; 51(3):370-6. DOI: 10.1159/000185325. View

17.

Maas R, Deegens J, Beukhof J, Reichert L, Ten Dam M, Beutler J . The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series. Am J Kidney Dis. 2017; 69(5):637-646. DOI: 10.1053/j.ajkd.2016.10.032. View

18.

Noone D, Iijima K, Parekh R . Idiopathic nephrotic syndrome in children. Lancet. 2018; 392(10141):61-74. DOI: 10.1016/S0140-6736(18)30536-1. View

19.

Fogo A, Hawkins E, Berry P, Glick A, Chiang M, MacDonell Jr R . Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis. Kidney Int. 1990; 38(1):115-23. DOI: 10.1038/ki.1990.175. View

20.

Denic A, Mathew J, Nagineni V, Thompson R, Leibovich B, Lerman L . Clinical and Pathology Findings Associate Consistently with Larger Glomerular Volume. J Am Soc Nephrol. 2018; 29(7):1960-1969. PMC: 6050922. DOI: 10.1681/ASN.2017121305. View